Certified by Founder Lodge
Ascidian Therapeutics
United States - Boston, MA
START UP
1 Disclosed Funding Rounds $50,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Ascidian Therapeutics is redefining the treatment of disease by rewriting RNA. By editing exons at the RNA level, Ascidian therapies enable precise post-transcriptional editing of genes, resu
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 17 ,2022 | Series A | $50,000,000 | |
| November, 09 ,2023 | Series A | $40,000,000.00 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Addis Energy | $4,250,000 | (Jan 23, 2025)
Kaya AI | $5,300,000 | (Jan 23, 2025)
Glue | $2,000,000 | (Jan 23, 2025)
Sonocharge Energy | $23,500,000 | (Jan 23, 2025)
Teal(US) | $7,500,000 | (Jan 23, 2025)
